Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector species
V920, rVSVΔG-ZEBOV-GP, is a recombinant vesicular stomatitis-Zaire ebolavirus vaccine which has shown an acceptable safety profile and provides a protective immune response against Ebola virus disease (EVD) induced by Zaire ebolavirus in humans. The purpose of this study was to determine whether the...
Saved in:
Main Authors: | Nicholas A. Bergren (Author), Megan R. Miller (Author), Thomas P. Monath (Author), Rebekah C. Kading (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2018-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Vesicular stomatitis virus-based vaccines protect nonhuman primates against Bundibugyo ebolavirus.
by: Chad E Mire, et al.
Published: (2013) -
Recombinant vesicular stomatitis virus vector vaccines for WHO blueprint priority pathogens
by: Anahita Fathi, et al.
Published: (2019) -
Accounting for population structure reveals ambiguity in the Zaire Ebolavirus reservoir dynamics.
by: Bram Vrancken, et al.
Published: (2020) -
Development of an antigen detection assay for early point-of-care diagnosis of Zaire ebolavirus.
by: Haley L DeMers, et al.
Published: (2020) -
Lessons learned from Zaire ebolavirus to help address urgent needs for vaccines against Sudan ebolavirus and Marburg virus
by: Daniel N. Wolfe, et al.
Published: (2020)